BellBrook

Veliparib (PARP1 & PARP2 Inhibitor)

As low as CHF 535.00
In stock
Only %1 left
BBL-5004-M02525 mgCHF 535.00
NEW
More Information
Product Details
Synonyms ABT-888; 2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide dihydrochloride
Product Type Chemical
Properties
Formula

C12H16N4O . 2HCl

MW 317.2
CAS 912445-05-7
Purity Chemicals ≥98% (TLC)
Appearance White solid.
Solubility Soluble in DMSO (30mg/ml) or water (40mg/ml)
Identity Determined by 1H-NMR.
InChi Key DSBSVDCHFMEYBX-FFXKMJQXSA-N
Smiles NC(C1=CC=CC2=C1N=C([C@@]3(NCCC3)C)N2)=O.Cl.Cl
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage +4°C
Use/Stability Stable for at least 1 year after receipt when stored at +4°C.
Stock solutions are stable for at least 3 months when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description

Veliparib 2HCl is a PARP1 and PARP2 inhibitor that has been fully validated using the Transcreener pADPr PARP Assay and Enzolution Assay Systems. An IC50 of 1.42 nM for PARP1 and an IC50 of 1.5 nM for PARP2 were obtained using a 12-point dose-response assay.

Described to be an inhibitor of PARP1 and PARP2 (Kis = 5.2 and 2.9 nM, respectively). Restores sensitivity to DNA alkylator/methylator temozolomide in glioma cells and xenografts and enhances radiotherapy sensitivity in endometrial carcinoma cells. Also improves sensitivity to DNA replication inhibitor cisplatin in human oral carcinoma cells.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.